News Highlight Therapeutics trials second-line melanoma combo aft... Cancer immunotherapy has set new standards in care, with some impressive responses in those patients lucky enough to respond.
News Former Seagen CEO Siegall pops up at new biotech Siegall resigned from Seagen last year amid claims of domestic abuse, though was not charged.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK